Expanding Japanese pharmaceutical manufacturing into a world-class business. - Japan CMO Association

  • Japanese
  • Contact us

Japan CMO Association

  • 業務委託をご検討中の企業様
  • ご入会をご検討中の企業様
  • 会員企業専用ページ
  1. TOP
  2. Overview

Overview of the Japan CMO Association (JCMOA)

The Japan CMO Association (JCMOA) was established in November 2010 when 18 contract manufacturing organizations (CMO) joined together for the purpose of undertaking research aimed at promoting the further growth and expansion of Japan’s CMO industry and resolving issues facing the industry; formulating voluntary guidelines related to the ideal form, etc., of appropriate contract manufacturing with pharmaceutical companies; formulating countermeasures to risks involved in contract manufacturing operations; collaborating with pharmaceutical organizations and regulatory authorities; and providing opinions.

Name Japan CMO Association
English name Japan CMO Association(JCMOA)
Established November, 2010
Membership Membership 34 companies
(Regular members: 24 companies, Supporting members: 10 companies) As of Jan, 2019
Chairman Qualitech Pharma Co.,Ltd. Shuichi Ando
Vice Chairman FUJIYAKUHIN Co.,Ltd. Naotake Eidai
Director Catalent Japan K.K. Tadahiro Matsumura
Director KOKANDO Co.,Ltd. Hiroshi Sakai
Director Sato Yakuhin Kogyo Co., Ltd. Tsukasa Zenitani
Director CMIC HOLDINGS Co.,Ltd. Takeshi Mitani
Director NIPRO CORPORATION Kouki Takemura
Director Fuji Pharma Co., Ltd. Takayuki Kasai
Director Bushu Pharmaceuticals Ltd. Masao Iyama
Auditor Daito Pharmaceutical Co., Ltd. Kazushige Hizume
  • ●Formulation of voluntary guidelines related to the appropriate implementation of pharmaceutical contract manufacturing operations.
  • ●Promotion of fair and strict pharmaceutical contract manufacturing in line with GMP, the Pharmaceutical and Medical Device Act, and other laws and regulations.
  • ●Promotion and research for the ideal state of scientific pharmaceutical manufacturing and quality assurance.
  • ●Research on and collection of information and materials, both in Japan and overseas, related to pharmaceutical contract manufacturing operations.
  • ●Advertising and public relations activities to promote the facilitation and improvement of pharmaceutical contract manufacturing.
  • ●Collaboration and exchange of opinions with related government agencies and various organizations.
  • ●Sharing information that contributes to the mutual advancement of member companies.
  • ●Mutual assistance when trouble related to pharmaceutical contract manufacturing arises
    (including the provision of alternative manufacturing facilities in times of emergency).
  • ●Education and training for workers involved with pharmaceutical manufacturing technology.
  • ●Others

Establishment of the CMO Case Example Study Group, holding of debriefing meetings on the activities of committees, presenting exhibits at INTERPHEX and other events, and creating plans for realizing communication with pharmacutical companies in order to boost contract manufacturing business for member companies, etc.

Secretariat Qualitech Pharma Co., Ltd.
20th Floor Shiodome Bldg, 1-2-20, Kaigan, Minato-ku Tokyo, 105-0022, Japan

About joining JCMOA